Diffuse Mesothelioma Payment Scheme

Jim Shannon Excerpts
Wednesday 11th February 2015

(9 years, 4 months ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Jim Shannon Portrait Jim Shannon (Strangford) (DUP)
- Hansard - -

It is a pleasure to speak in this debate. I thank the hon. Member for Liverpool, Walton (Steve Rotheram) for securing it and for giving us all a chance to participate and give a viewpoint—I will obviously give a Northern Ireland viewpoint. It is also a pleasure, as always, to follow the hon. Member for Chatham and Aylesford (Tracey Crouch) and to hear her contribution.

This issue has affected a great number of people in my constituency of Strangford and, indeed, across the whole of Northern Ireland. I thank the Minister for his announcement, but I seek clarification on how the compensation will affect Northern Ireland. I am aware that the Northern Ireland Assembly made a decision in 2012 on the issue. I will ask him some questions on that later, because it is important to get the situation and how the compensation payments will affect those in Northern Ireland entirely clarified. When I comment on that later, hon. Members will see the clear disparity between Northern Ireland and the rest of the United Kingdom. Those are important issues.

This is a common disease, particularly among the older generation and particularly in the old industrial towns of Belfast. With Harland and Wolff employing some 15,000 workers in the shipyards, and as many as 30,000 workers at one stage, it is unsurprising that so many men—and also women—in and around Belfast were affected by asbestos-related illnesses. For many plumbers, electricians and builders working in the ’50s and ’60s in towns within and outside the shipyards, asbestos was commonplace, so unsurprisingly a large number of people in my constituency have been affected. Indeed, the story is told that when Harland and Wolff was at its height, the asbestos flakes were of such enormity and quantity that they were in the streets of east Belfast, where the children played among them, never realising that doing so would be detrimental to their health, so it is not necessarily just the workers in the shipyard who were affected, but those outside it. Over some 30 years as an elected representative—I was doing the figures the other day; figures are always a reminder of how many years we have been on this earth—as a councillor, a Member of the Northern Ireland Assembly and, now, as a Member of Parliament here, I have had occasion to represent many of my constituents on this issue in relation to their benefits and their compensation claims as well.

Malignant mesothelioma is the most serious of all asbestos-related diseases. As has been mentioned, exposure to asbestos is the primary cause and a risk factor for mesothelioma. Making a correct mesothelioma diagnosis is particularly difficult for doctors because the disease often presents with symptoms that mimic other common ailments, so people may sometimes not be aware of exactly what is happening. There is currently no cure for mesothelioma, but treatments are available to help with the typical mesothelioma prognosis.

It is clear that investment in research into mesothelioma is desperately needed. The United Kingdom has the highest rate of the disease in the world—that is not something to be proud of, but it is a fact of life that we have the highest figures. That is largely because the UK Government permitted the use of asbestos long after other countries outlawed the mineral’s use. In addition, and as mentioned previously, shipbuilders historically are among the people most affected by mesothelioma, and the shipbuilding industry plays a large role in the history of the United Kingdom, in particular in Belfast and Northern Ireland, especially around the time of second world war. The British Lung foundation has said that this year, it is estimated that 2,400 people will die of the disease, and that over the next 30 years, more than 50,000 people will die of mesothelioma in the UK unless new treatments are found. The hon. Members for Liverpool, Walton and for Chatham and Aylesford both mentioned the need to do more research and to try more actively to find a cure.

Gregory Campbell Portrait Mr Gregory Campbell (East Londonderry) (DUP)
- Hansard - - - Excerpts

My hon. Friend is talking about heavy industry and the shipyards, and the impact that they had. Given that the numbers of people dying from mesothelioma are continuing to increase post that revolution, that would indicate that the research that he is talking about—and is generally agreed should increase—should be where the effort is concentrated after the announcement yesterday that greater research has to be done for the future.

Jim Shannon Portrait Jim Shannon
- Hansard - -

I thank my hon. Friend and colleague for that intervention. Yes, that needs to happen. I know that this Minister is not responsible for health, but perhaps he could give us some idea of what discussions he may have had with the relevant Health Minister on finding a cure or treatment that works and is more effective.

Relatively little is spent on mesothelioma research in the United Kingdom compared with other cancers of comparable mortality. In 2011, the National Cancer Research Institute reported that £400,000 was invested in mesothelioma research by its partners. That seems like a lot of money, but compared with figures for research today, it is not, so we need some indication of how that will be increased. The amount compares with some £5 million and some £5.5 million spent respectively on myeloma and melanoma—two cancers that kill a similar number of people each year—in the same year.

Given how aggressive this cancer is, it surprises me, but also saddens me, that in 2015 we are still not working hard enough to find a cure. That is the very issue to which my hon. Friend the Member for East Londonderry (Mr Campbell) referred. I was pleased to see that the Northern Ireland Assembly introduced a scheme to help those not just affected first hand, but who had come into contact through relatives—by washing clothes, for example, which is how many of the wives, girlfriends, mothers and children have been directly affected by what has happened. On 1 October 2008, the scheme was launched and then, last year a scheme was introduced in the UK. Although it is similar, there are some key differences, and it is those key differences that concern me most. I will focus on those quickly and seek the Minister’s response on them; his help would be greatly appreciated.

In Northern Ireland, a person—this includes dependants—has to claim within 12 months of receiving a diagnosis or within 12 months of receiving an industrial injuries disablement benefit. On the UK mainland, a person has three years to make the claim. That is quite a difference, so I seek to clarify how and what methods can be used to address that issue. The scheme is also open only to those diagnosed on or after 25 July 2012. That automatically cuts out a large proportion of the community, because so many of those who worked in the ’50s and ’60s and before that were diagnosed some time ago. That means that they are directly disadvantaged and excluded. That simply should not be the case, because every person affected by this cancer deserves some form of compensation. Unfortunately, compensation will not make them better; but what it does do, importantly, is help them in some way, and it is what is deserved, so it just seems like a no-brainer to me that we should be doing our best to help them.

Not only that, but there is a significant disparity between compensation payments in Northern Ireland and those on the UK mainland. Both systems work on the same basis, so the younger someone is, the more compensation they receive. In Northern Ireland, if a person is aged 37 or under, they will receive just over £80,000 as a lump sum. At the other end of the spectrum, if a person is aged 77 or over, they receive just over £12,500. At the same time, in the UK mainland, someone aged 40 or under will receive just over £216,000, and a person aged 90 or over will receive just under £70,000. There is a massive disparity in payouts. It is quite shocking to see such a difference, so I seek an explanation from the Minister and perhaps his help on how we can make progress, so that there is a similarity between payouts across the whole of the United Kingdom of Great Britain and Northern Ireland.

Mesothelioma does not change. It does not stop at the Irish sea, nor does it lessen when it crosses the Irish sea, so it disappoints me that people living in Northern Ireland are afforded so much less because of their postcode. Last January, I asked the Secretary of State for Health what discussions he had had with his counterparts in Northern Ireland about introducing this strategy on a UK-wide basis. He said at the time that he had not had any discussions with them. A year on, I put the same question, this time to the Minister present in the Chamber. What discussions have taken place with his counterparts in Northern Ireland about a UK-wide strategy to tackle mesothelioma, so that everyone in the United Kingdom and Northern Ireland can have the same payouts, the same compensation and the same help?

--- Later in debate ---
Mark Harper Portrait The Minister for Disabled People (Mr Mark Harper)
- Hansard - - - Excerpts

It is a great pleasure to serve under your chairmanship, Mr Owen. I congratulate the hon. Member for Liverpool, Walton (Steve Rotheram) on securing this debate. He takes a close interest in asbestos-related issues. A little while ago, we both took part in an Adjournment debate on other issues related to asbestos and safety.

I start by echoing the hon. Gentleman’s sentiments towards the late Paul Goggins. I remember very clearly the debate in the House on the Mesothelioma Act 2014 shortly after his sad death. I also echo the hon. Gentleman’s generous comments about my hon. Friend the Member for Chatham and Aylesford (Tracey Crouch), who picked up the baton on that occasion, although I do not echo his comments about football. Coming from Gloucestershire, which is a rugby-playing part of the world, I should probably leave the football dispute to other people. [Interruption.] It is probably not good for me to talk about rugby in your presence, Mr Owen, so we will move on.

This has been a very good debate, and it has been helpful in the context of yesterday’s written statement. I will answer some of the questions that colleagues have raised. Following some of the contributions, including from the shadow Minister, it is worth briefly placing on record that the scheme that was legislated for last year, the Diffuse Mesothelioma Payment Scheme, is of course not the only scheme in statute to address such difficult issues. The Pneumoconiosis etc. (Workers’ Compensation) Act 1979 set up the first scheme. That had significant gaps in it, which is why the previous Government, with the support of the then Conservative Opposition, introduced the 2008 scheme in the Child Maintenance and Other Payments Act 2008, which deals with those who did not necessarily work in the industry, but were self-employed, or, in some cases, family members of those who worked in the industry. This scheme comes in the wake of that to deal with some of the issues that those schemes did not deal with.

It is worth putting on the record the scope of the schemes. Although the hon. Member for Strangford (Jim Shannon) mentioned them, the 1979 scheme and the 2008 scheme are both Great Britain schemes, so they do not apply to Northern Ireland. The responsibility for welfare policy lies with the Northern Ireland Executive. The 2014 scheme, which we are discussing today, is a UK-wide scheme and applies in Northern Ireland as well as England, Scotland and Wales.

To pick up the point raised by the hon. Member for Strangford, people in Northern Ireland have three years to apply for the scheme from the point of diagnosis, which is the same as in England, Scotland and Wales, so I do not think there is a difference in the way the scheme operates. However, he is right to point out that the previous two schemes do not apply in Northern Ireland.

Jim Shannon Portrait Jim Shannon
- Hansard - -

I thank the Minister for giving way; he knows I have to leave fairly shortly and I wanted to intervene in advance of that. After the announcement has been made, when does the Minister hope to have direct contact with the Minister responsible in the Northern Ireland Assembly so that we can co-ordinate the delivery of the compensation plan for the whole of the United Kingdom—Great Britain and Northern Ireland?

Mark Harper Portrait Mr Harper
- Hansard - - - Excerpts

I referred to the hon. Gentleman’s point first because I know that he has other pressing business on behalf of his constituents, and he had the courtesy to let me know, so I wanted to deal with his point while he was still in the Chamber. As he knows, I plan to meet the Northern Ireland Minister with responsibility for welfare to discuss other matters to do with welfare in the wake of the Stormont House agreement. I will ask my officials to place this issue on the agenda and we can have a conversation about that to make sure it is clear how it will be implemented in Northern Ireland.

One point flowed through the remarks of the hon. Members for Liverpool, Walton and for Stretford and Urmston (Kate Green) and my hon. Friend the Member for Chatham and Aylesford. I will set out my understanding of the position, which is clear. There was a lot of discussion about the levy on the industry. The scheme is effectively demand-led: people make applications to it and the costs of the scheme are then recovered through a levy on the industry. The 3% that has been talked about is a cap. The insurance industry agreed that if the cost remained below that level, it would absorb the cost of the scheme and would not pass it on to other employers who take out employers’ liability insurance through increased premiums. That was important. The Government did not want the cost of the scheme to fall on employers across Britain: we wanted it to be absorbed by the insurance industry.

So the 3% is a cap, not a target. The costs of the scheme are calculated and then the levy is calculated to recover the costs of the scheme. The hon. Members for Liverpool, Walton, for Strangford and for Stretford and Urmston referred to Lord Freud’s written statement on 28 November last year. He set out the costs of the scheme in the first period of the year, how much that encompassed and how much would therefore be recovered from the insurance industry. That position is clear. [Interruption.] Let me finish this thought and then I will take a question.

Hon. Members seem to have envisaged, although it was not envisaged by the Government, that there would be a 3% levy, some of the money from which would be used for settling claims and the rest would form a pot of money that could be distributed as Ministers or others saw fit. However, it is a cap on the costs that land on the industry. The industry agreed that if that remained the cap, it would absorb the costs of the scheme and not pass them on to employers more generally.